IMMUNE-MEDIATED HYPOPITUITARISM

IMMUNE-MEDIATED HYPOPITUITARISM was reported 33 times

IMMUNE-MEDIATED HYPOPITUITARISM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CTLA-4-directed Blocking Antibody [EPC] 16 0.0003
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 25 0.0003
2 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
3 beta3-Adrenergic Agonist [EPC] 1 0.0000
4 Platinum-based Drug [EPC] 4 0.0000
5 Microtubule Inhibitor [EPC] 2 0.0000
6 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
7 Alkylating Drug [EPC] 1 0.0000
8 Kinase Inhibitor [EPC] 1 0.0000